80 research outputs found

    SAM Format - Representation and Mapping of DNA Sequences

    Get PDF
    Cílem této bakalářské práce je implementace programu převádějícího již namapované sekvence DNA do formátu SAM. Na vstupu programu budou sekvence DNA s již přiřazenými souřadnicemi. Tyto sekvence budou zarovnány algoritmem Needleman-Wunsch a ke každé z těchto sekvencí budou doplněny povinné atributy definované ve specifikaci formátu Sam. Především CIGAR řetězec a následně kvalita mapování.The aim of this thesis is to implement a program that converts already mapped DNA sequences into SAM format. At the input of the program there will be DNA sequences with already assigned coordinates. These sequences will be aligned by Needleman-Wunsch algorithm and the mandatory attributes defined in the SAM format specification will be added to each of these sequences. Especially CIGAR string and consequently mapping quality.460 - Katedra informatikydobř

    Multi-seasonal systematic camera-trapping reveals fluctuating densities and high turnover rates of Carpathian lynx on the western edge of its native range

    Get PDF
    Camera-trapping and capture-recapture models are the most widely used tools for estimating densities of wild felids that have unique coat patterns, such as Eurasian lynx. However, studies dealing with this species are predominantly on a short-term basis and our knowledge of temporal trends and population persistence is still scarce. By using systematic camera-trapping and spatial capture-recapture models, we estimated lynx densities and evaluated density fluctuations, apparent survival, transition rate and individual's turnover during five consecutive seasons at three different sites situated in the Czech-Slovak-Polish borderland at the periphery of the Western Carpathians. Our density estimates vary between 0.26 and 1.85 lynx/100 km2 suitable habitat and represent the lowest and the highest lynx densities reported from the Carpathians. We recorded 1.5-4.1-fold changes in asynchronous fluctuated densities among all study sites and seasons. Furthermore, we detected high individual's turnover (on average 46.3 +- 8.06% in all independent lynx and 37.6 +- 4.22% in adults) as well as low persistence of adults (only 3 out of 29 individuals detected in all seasons). The overall apparent survival rate was 0.63 +- 0.055 and overall transition rate between sites was 0.03 +- 0.019. Transition rate of males was significantly higher than in females, suggesting male-biased dispersal and female philopatry. Fluctuating densities and high turnover rates, in combination with documented lynx mortality, indicate that the population in our region faces several human-induced mortalities, such as poaching or lynx-vehicle collisions. These factors might restrict population growth and limit the dispersion of lynx to other subsequent areas, thus undermining the favourable conservation status of the Carpathian population. Moreover, our study demonstrates that long-term camera-trapping surveys are needed for evaluation of population trends and for reliable estimates of demographic parameters of wild territorial felids, and can be further used for establishing successful management and conservation measures.Postprin

    Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND). a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

    Get PDF
    Background: Although several disease-modifying treatments are available for relapsing multiple sclerosis, treatment effects have been more modest in progressive multiple sclerosis and have been observed particularly in actively relapsing subgroups or those with lesion activity on imaging. We sought to assess whether natalizumab slows disease progression in secondary progressive multiple sclerosis, independent of relapses. Methods: ASCEND was a phase 3, randomised, double-blind, placebo-controlled trial (part 1) with an optional 2 year open-label extension (part 2). Enrolled patients aged 18–58 years were natalizumab-naive and had secondary progressive multiple sclerosis for 2 years or more, disability progression unrelated to relapses in the previous year, and Expanded Disability Status Scale (EDSS) scores of 3·0–6·5. In part 1, patients from 163 sites in 17 countries were randomly assigned (1:1) to receive 300 mg intravenous natalizumab or placebo every 4 weeks for 2 years. Patients were stratified by site and by EDSS score (3·0–5·5 vs 6·0–6·5). Patients completing part 1 could enrol in part 2, in which all patients received natalizumab every 4 weeks until the end of the study. Throughout both parts, patients and staff were masked to the treatment received in part 1. The primary outcome in part 1 was the proportion of patients with sustained disability progression, assessed by one or more of three measures: the EDSS, Timed 25-Foot Walk (T25FW), and 9-Hole Peg Test (9HPT). The primary outcome in part 2 was the incidence of adverse events and serious adverse events. Efficacy and safety analyses were done in the intention-to-treat population. This trial is registered with ClinicalTrials.gov, number NCT01416181. Findings: Between Sept 13, 2011, and July 16, 2015, 889 patients were randomly assigned (n=440 to the natalizumab group, n=449 to the placebo group). In part 1, 195 (44%) of 439 natalizumab-treated patients and 214 (48%) of 448 placebo-treated patients had confirmed disability progression (odds ratio [OR] 0·86; 95% CI 0·66–1·13; p=0·287). No treatment effect was observed on the EDSS (OR 1·06, 95% CI 0·74–1·53; nominal p=0·753) or the T25FW (0·98, 0·74–1·30; nominal p=0·914) components of the primary outcome. However, natalizumab treatment reduced 9HPT progression (OR 0·56, 95% CI 0·40–0·80; nominal p=0·001). In part 1, 100 (22%) placebo-treated and 90 (20%) natalizumab-treated patients had serious adverse events. In part 2, 291 natalizumab-continuing patients and 274 natalizumab-naive patients received natalizumab (median follow-up 160 weeks [range 108–221]). Serious adverse events occurred in 39 (13%) patients continuing natalizumab and in 24 (9%) patients initiating natalizumab. Two deaths occurred in part 1, neither of which was considered related to study treatment. No progressive multifocal leukoencephalopathy occurred. Interpretation: Natalizumab treatment for secondary progressive multiple sclerosis did not reduce progression on the primary multicomponent disability endpoint in part 1, but it did reduce progression on its upper-limb component. Longer-term trials are needed to assess whether treatment of secondary progressive multiple sclerosis might produce benefits on additional disability components. Funding: Biogen

    Prerequisites for coexistence: human pressure and refuge habitat availability shape continental‑scale habitat use patterns of a large carnivore

    Get PDF
    Context Adjustments in habitat use by large carnivores can be a key factor facilitating their coexistence with people in shared landscapes. Landscape composition might be a key factor determining how large carnivores can adapt to occurring alongside humans, yet broad-scale analyses investigating adjustments of habitat use across large gradients of human pressure and landscape composition are lacking. Objectives Here, we investigate adjustments in habitat use by Eurasian lynx (Lynx lynx) in response to varying availability of refuge habitats (i.e., forests and rugged terrain) and human landscape modifcation. Methods Using a large tracking dataset including 434 individuals from seven populations, we assess functional responses in lynx habitat use across two spatial scales, testing for variation by sex, daytime, and season. Results We found that lynx use refuge habitats more intensively with increasing landscape modifcation across spatial scales, selecting forests most strongly in otherwise open landscapes and rugged terrain in mountainous regions. Moreover, higher forest availability enabled lynx to place their home ranges in more human-modifed landscapes. Human pressure and refuge habitat availability also shaped temporal patterns of lynx habitat use, with lynx increasing refuge habitat use and reducing their use of human-modifed areas during periods of high exposure (daytime) or high vulnerability (postnatal period) to human pressure. Conclusions Our fndings suggest a remarkable adaptive capacity of lynx towards human pressure and underline the importance of refuge habitats across scales for enabling coexistence between large carnivores and people. More broadly, we highlight that the composition of landscapes determines how large carnivores can adapt to human pressure and thus play an important role shaping large carnivore habitat use and distributions.publishedVersio

    Integrating animal tracking datasets at a continental scale for mapping Eurasian lynx habitat

    Get PDF
    Aim: The increasing availability of animal tracking datasets collected across many sites provides new opportunities to move beyond local assessments to enable de-tailed and consistent habitat mapping at biogeographical scales. However, integrating wildlife datasets across large areas and study sites is challenging, as species' varying responses to different environmental contexts must be reconciled. Here, we compare approaches for large-area habitat mapping and assess available habitat for a recolo-nizing large carnivore, the Eurasian lynx (Lynx lynx).Location: Europe.Methods: We use a continental-scale animal tracking database (450 individuals from 14 study sites) to systematically assess modelling approaches, comparing (1) global strategies that pool all data for training versus building local, site-specific models and combining them, (2) different approaches for incorporating regional variation in habi-tat selection and (3) different modelling algorithms, testing nonlinear mixed effects models as well as machine-learning algorithms.Results: Testing models on training sites and simulating model transfers, global and local modelling strategies achieved overall similar predictive performance. Model performance was the highest using flexible machine-learning algorithms and when incorporating variation in habitat selection as a function of environmental variation. Our best-performing model used a weighted combination of local, site-specific habi-tat models. Our habitat maps identified large areas of suitable, but currently unoccu-pied lynx habitat, with many of the most suitable unoccupied areas located in regions that could foster connectivity between currently isolated populations.Main Conclusions: We demonstrate that global and local modelling strategies can achieve robust habitat models at the continental scale and that considering regional variation in habitat selection improves broad-scale habitat mapping. More generally, we highlight the promise of large wildlife tracking databases for large-area habitat mapping. Our maps provide the first high-resolution, yet continental assessment of lynx habitat across Europe, providing a consistent basis for conservation planning for restoring the species within its former range.publishedVersio

    Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

    Get PDF
    BACKGROUND: Biopharmaceutical products (BPs) are widely used to treat autoimmune diseases, but immunogenicity limits their efficacy for an important proportion of patients. Our knowledge of patient-related factors influencing the occurrence of antidrug antibodies (ADAs) is still limited. METHODS AND FINDINGS: The European consortium ABIRISK (Anti-Biopharmaceutical Immunization: prediction and analysis of clinical relevance to minimize the RISK) conducted a clinical and genomic multicohort prospective study of 560 patients with multiple sclerosis (MS, n = 147), rheumatoid arthritis (RA, n = 229), Crohn's disease (n = 148), or ulcerative colitis (n = 36) treated with 8 different biopharmaceuticals (etanercept, n = 84; infliximab, n = 101; adalimumab, n = 153; interferon [IFN]-beta-1a intramuscularly [IM], n = 38; IFN-beta-1a subcutaneously [SC], n = 68; IFN-beta-1b SC, n = 41; rituximab, n = 31; tocilizumab, n = 44) and followed during the first 12 months of therapy for time to ADA development. From the bioclinical data collected, we explored the relationships between patient-related factors and the occurrence of ADAs. Both baseline and time-dependent factors such as concomitant medications were analyzed using Cox proportional hazard regression models. Mean age and disease duration were 35.1 and 0.85 years, respectively, for MS; 54.2 and 3.17 years for RA; and 36.9 and 3.69 years for inflammatory bowel diseases (IBDs). In a multivariate Cox regression model including each of the clinical and genetic factors mentioned hereafter, among the clinical factors, immunosuppressants (adjusted hazard ratio [aHR] = 0.408 [95% confidence interval (CI) 0.253-0.657], p < 0.001) and antibiotics (aHR = 0.121 [0.0437-0.333], p < 0.0001) were independently negatively associated with time to ADA development, whereas infections during the study (aHR = 2.757 [1.616-4.704], p < 0.001) and tobacco smoking (aHR = 2.150 [1.319-3.503], p < 0.01) were positively associated. 351,824 Single-Nucleotide Polymorphisms (SNPs) and 38 imputed Human Leukocyte Antigen (HLA) alleles were analyzed through a genome-wide association study. We found that the HLA-DQA1*05 allele significantly increased the rate of immunogenicity (aHR = 3.9 [1.923-5.976], p < 0.0001 for the homozygotes). Among the 6 genetic variants selected at a 20% false discovery rate (FDR) threshold, the minor allele of rs10508884, which is situated in an intron of the CXCL12 gene, increased the rate of immunogenicity (aHR = 3.804 [2.139-6.764], p < 1 × 10-5 for patients homozygous for the minor allele) and was chosen for validation through a CXCL12 protein enzyme-linked immunosorbent assay (ELISA) on patient serum at baseline before therapy start. CXCL12 protein levels were higher for patients homozygous for the minor allele carrying higher ADA risk (mean: 2,693 pg/ml) than for the other genotypes (mean: 2,317 pg/ml; p = 0.014), and patients with CXCL12 levels above the median in serum were more prone to develop ADAs (aHR = 2.329 [1.106-4.90], p = 0.026). A limitation of the study is the lack of replication; therefore, other studies are required to confirm our findings. CONCLUSION: In our study, we found that immunosuppressants and antibiotics were associated with decreased risk of ADA development, whereas tobacco smoking and infections during the study were associated with increased risk. We found that the HLA-DQA1*05 allele was associated with an increased rate of immunogenicity. Moreover, our results suggest a relationship between CXCL12 production and ADA development independent of the disease, which is consistent with its known function in affinity maturation of antibodies and plasma cell survival. Our findings may help physicians in the management of patients receiving biotherapies

    Enhancing the prospectivity of the Wyville Thomson Ridge

    Get PDF
    Føroya Kolvetni (Faroe Petroleum) was awarded Licence 012, covering part of the Wyville Thomson Ridge, in the second Faroese Licensing Round and this paper summarises some initial results from their work programme. Interest in the prospectivity of the Wyville Thomson Ridge was stimulated in the 1990s by a proposal that it forms a compressional anticline with a thin carapace of Paleogene lavas, overlying an inverted sedimentary basin. Gravity interpretation confirms that the ridge can be modelled as an inverted basin, although uncertainties inherent in the method limit the accuracy of the thickness estimates. Seismic reflection data shot in 2005 provide improved resolution of the pre-lava succession, with some reflector packages resembling seismic facies from the prospective Paleocene succession in the Faroe-Shetland Basin. The Rannvá exploration lead consists of an extremely large four-way dip closure beneath thin lavas at the crest of the Wyville Thomson Ridge. Source rock presence and maturity, hydrocarbon migration, and reservoir development in the Licence 012 area are discussed on the basis of regional observations

    Determination of ATP binding site of Na+/K+-ATPase.

    No full text
    Cells evolve several types of membrane transporters, but the mechanism of their function is not yet completely understood. The aim of the study was the transporter of sodium and potassium ions, Na+/K+-ATPase, often called sodium pump. Na+/K+-ATPase is a member of P-type ATPase family that contains enzymes with similar structural and functional features. A significant progress to understand the structure of these enzymes was brought by recent studies of crystal structure of Ca2+-ATPase in both comformations of this enzyme. They seem to have solved important questions concerning the number of transmembrane helices or the number of ATP binding sites, which were intensively discussed namely in the case of Na+/K+-ATPase. The main problem was to determinate the structure of the ATP-binding site.Available from STL Prague, CZ / NTK - National Technical LibrarySIGLECZCzech Republi

    Easement of areas designated for overflowing of floods

    Get PDF
    Easement of areas designated for overflowing of floods - Abstract The aim of this thesis is to elaborate and subsequently provide an analysis of the current legal regulation of the easement of areas designated for overflowing of floods in Czech civil law. With regard to the historical development of easements as a superior concept of the easement of areas designated for overflowing of floods, as well as with regard to the regulation of a similar institute, which is the area designated for controlled flood overflowing under the Water Act. This thesis focuses on approaching the relatively young institute of the easement of areas designated for overflowing of floods in Czech civil law, clarifying its basic essence and its use in practice. The first chapter briefly outlines the basic characteristics of easements and their subdivision. The second chapter of the thesis briefly outlines the basic characteristics of the easement of areas designated for overflowing of floods. In the third chapter, this thesis focuses on the historical development of easements from Roman law until the Civil Code of 1964, focusing on the general historical development of easements in the absence of specific regulation of the easement of areas designated for overflowing of floods in this historical development. The greatest emphasis in..
    corecore